Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.32 | 0.07 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |